| Entry |
|
|---|
| Name |
Cenobamate (USAN/INN);
Xcopri (TN) |
|---|
| Product |
|
|---|
| Formula |
C10H10ClN5O2
|
|---|
| Exact mass |
267.0523
|
|---|
| Mol weight |
267.6717
|
|---|
| Structure |
|
|---|
| Class |
|
|---|
| Remark |
|
|---|
| Efficacy |
Analgesic, Antiepileptic |
|---|
| Comment |
Treatment of partial-onset seizures
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Metabolism |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX25 Cenobamate
D11150 Cenobamate (USAN/INN) <US>
USP drug classification [BR:br08302]
Anticonvulsants
Anticonvulsants, Other
Cenobamate
D11150 Cenobamate (USAN/INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01638 CYP2A6 substrate
D11150 Cenobamate
DG02919 CYP2B6 substrate
D11150 Cenobamate
DG01639 CYP2C19 substrate
D11150 Cenobamate
DG02855 CYP2E1 substrate
D11150 Cenobamate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D11150 Cenobamate
DG02925 CYP3A5 substrate
D11150 Cenobamate
DG02924 UGT substrate
DG03189 UGT2B4 substrate
D11150 Cenobamate
DG03190 UGT2B7 substrate
D11150 Cenobamate
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D11150 Cenobamate (USAN/INN) <US>
Voltage-gated ion channels
Sodium channels
SCN1A
D11150 Cenobamate (USAN/INN) <US>
SCN2A
D11150 Cenobamate (USAN/INN) <US>
SCN3A
D11150 Cenobamate (USAN/INN) <US>
SCN4A
D11150 Cenobamate (USAN/INN) <US>
SCN5A
D11150 Cenobamate (USAN/INN) <US>
SCN8A
D11150 Cenobamate (USAN/INN) <US>
SCN9A
D11150 Cenobamate (USAN/INN) <US>
SCN10A
D11150 Cenobamate (USAN/INN) <US>
SCN11A
D11150 Cenobamate (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11150
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11150
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11150
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11150
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 C8x C 10.6400 -26.0400
2 C8x C 10.6400 -27.4400
3 C8x C 11.8524 -28.1400
4 C8y C 13.0649 -27.4400
5 C8y C 13.0649 -26.0400
6 C8x C 11.8524 -25.3400
7 X Cl 14.2960 -28.1510
8 C1c C 14.2960 -25.3290
9 O7a O 15.5012 -26.0247
10 C1b C 14.2957 -23.9401
11 C7a C 16.6835 -25.3419
12 N1a N 17.8775 -26.0312
13 O6a O 16.6835 -23.9402
14 N4y N 13.0714 -23.2334
15 N5x N 13.0557 -21.8404
16 C8x C 11.7275 -21.4260
17 N5x N 10.9229 -22.5612
18 N5x N 11.7539 -23.6772
BOND 19
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 5 8 1
9 8 9 1 #Down
10 8 10 1
11 9 11 1
12 11 12 1
13 11 13 2
14 10 14 1
15 14 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 14 18 1
|
|---|
